160 related articles for article (PubMed ID: 6894424)
21. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
[TBL] [Abstract][Full Text] [Related]
22. Comparison of acute effects of 1.25- and 24.25-dihydroxy-vitamin D3 in normal subjects.
Heynen G; Cornet F; Franchimont P; Gaspar S; Plomteux G; Cession-Fossion G; Russel RG; Kanis JA
Acta Endocrinol (Copenh); 1981 Dec; 98(4):619-24. PubMed ID: 6975547
[TBL] [Abstract][Full Text] [Related]
23. Parathyroid hormone is not involved in 1,25-dihydroxyvitamin D regulation of 25-hydroxyvitamin D metabolism in vivo.
Castillo L; Tanaka Y; DeLuca HF
Biochem Biophys Res Commun; 1981 Jun; 100(3):1332-6. PubMed ID: 6973974
[No Abstract] [Full Text] [Related]
24. Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.
Neer RM; Holick MF; DeLuca HF; Potts JT
Metabolism; 1975 Dec; 24(12):1403-13. PubMed ID: 1196134
[TBL] [Abstract][Full Text] [Related]
25. [Effect of vitamin D3 and its metabolites 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol on callus mineralization in rats with femoral fracture].
Blazhevich NV; Sergeev IN; Arkhapchev IuP; Isaeva VA; Spirichev VB
Vopr Med Khim; 1982; 28(6):98-105. PubMed ID: 6297167
[TBL] [Abstract][Full Text] [Related]
26. Suppressive effects of 24,25-dihydroxycholecalciferol on bone resorption induced by acute bilateral nephrectomy in rats.
Pavlovitch JH; Cournot-Witmer G; Bourdeau A; Balsan S; Fischer JA; Heynen G
J Clin Invest; 1981 Sep; 68(3):803-810. PubMed ID: 6974178
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
28. Effect of dietary calcium, phosphate and vitamin D deprivation on the pharmacokinetics of 1,25-dihydroxyvitamin D3 in the rat.
Jongen MJ; Bishop JE; Cade C; Norman AW
Horm Metab Res; 1987 Oct; 19(10):481-5. PubMed ID: 3428866
[TBL] [Abstract][Full Text] [Related]
29. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
30. Lack of a direct effect of 1,25-dihydroxycholecalciferol on parathyroid hormone secretion by normal bovine parathyroid glands.
Golden P; Greenwalt A; Martin K; Bellorin-Font E; Mazey R; Klahr S; Slatopolsky E
Endocrinology; 1980 Aug; 107(2):602-7. PubMed ID: 6893023
[TBL] [Abstract][Full Text] [Related]
31. Phosphatemic action of 1,25-dihydroxyvitamin D3.
Steele TH; Engle JE; Tanaka Y; Lorenc RS; Dudgeon KL; DeLuca HF
Am J Physiol; 1975 Aug; 229(2):489-95. PubMed ID: 1163676
[TBL] [Abstract][Full Text] [Related]
32. Intestinal calcium-binding protein (CaBP) and bone calcium mobilization in response to 1,24(R),25-(OH)3D3. Comparative effects of 1,25-(OH)2D3 and 24(R),25-(OH)2D3 in rats.
Thomasset M; Cuisinier-Gleizes P; Mathieu H; DeLuca HF
Mol Pharmacol; 1980 May; 17(3):362-6. PubMed ID: 6967147
[No Abstract] [Full Text] [Related]
33. Effects of oxidation of human parathyroid hormone on its biological activity in continuously infused, thyroparathyroidectomized rats.
Horiuchi N
J Bone Miner Res; 1988 Jun; 3(3):353-8. PubMed ID: 3213628
[TBL] [Abstract][Full Text] [Related]
34. Effect of dietary calcium on the response of bone to 1,25 (OH)2D3.
Boyce RW; Weisbrode SE
Lab Invest; 1983 Jun; 48(6):683-9. PubMed ID: 6687909
[TBL] [Abstract][Full Text] [Related]
35. Effects of serum calcium and phosphorus on skeletal mineralization in vitamin D-deficient rats.
Holtrop ME; Cox KA; Carnes DL; Holick MF
Am J Physiol; 1986 Aug; 251(2 Pt 1):E234-40. PubMed ID: 3740259
[TBL] [Abstract][Full Text] [Related]
36. Bone and serum concentrations of osteocalcin as a function of 1,25-dihydroxyvitamin D3 circulating levels in bone disorders in rats.
Lian JB; Carnes DL; Glimcher MJ
Endocrinology; 1987 May; 120(5):2123-30. PubMed ID: 3494594
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D3 metabolite injections to thyroparathyroidectomized pregnant rats: effects on calcium-binding proteins of maternal duodenum and of fetoplacental unit.
Garel JM; Delorme AC; Marche P; Nguyen TM; Garabedian M
Endocrinology; 1981 Jul; 109(1):284-9. PubMed ID: 6263587
[TBL] [Abstract][Full Text] [Related]
38. Early actions of parathyroid hormone and 1,25-dihydroxycholecalciferol on isolated epithelial cells from rat intestine: I. Limited lysosomal enzyme release and calcium uptake.
Nemere I; Szego CM
Endocrinology; 1981 Apr; 108(4):1450-62. PubMed ID: 6894118
[TBL] [Abstract][Full Text] [Related]
39. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
Sergeev IN; Blazheevich NV; Kaplanskiĭ AS; Shvets VN; Belakovskiĭ MS
Vopr Med Khim; 1987; 33(1):100-7. PubMed ID: 3495067
[TBL] [Abstract][Full Text] [Related]
40. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
